Page last updated: 2024-08-16
ro 31-8220 and aspirin
ro 31-8220 has been researched along with aspirin in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ciampa, MT; Favilla, M; Gazzaniga, PP; Pignatelli, P; Pulcinelli, FM; Riondino, S | 1 |
| Flescher, E; Rotem, R | 1 |
Other Studies
2 other study(ies) available for ro 31-8220 and aspirin
| Article | Year |
|---|---|
Concomitant activation of Gi protein-coupled receptor and protein kinase C or phospholipase C is required for platelet aggregation.
Topics: Adenosine Diphosphate; Aspirin; Chelating Agents; Crotalid Venoms; Egtazic Acid; Enzyme Activation; Epinephrine; GTP-Binding Proteins; Humans; Indoles; Lectins, C-Type; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Tetradecanoylphorbol Acetate; Type C Phospholipases | 1999 |
Protein kinase C epsilon mediates the induction of P-glycoprotein in LNCaP prostate carcinoma cells.
Topics: Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Diterpenes; Enzyme Inhibitors; Flow Cytometry; Humans; Indoles; Isoenzymes; Kinetics; Male; Peptide Fragments; Prostatic Neoplasms; Protein Kinase C-epsilon; Protein Transport; Tumor Cells, Cultured | 2002 |